{"id":"F2007B01057","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 5 of 1990)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-1990","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62537,"registerId":"commonwealth-F2007B01057-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 5 of 1990)","content":"COMMONWEALTH OF AUSTRALIA\n\nNATIONAL HEALTH ACT 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUB-SECTION 85(2AA)\n\nNo. PB5 of 1990\n\nI, MARGARET NONA FORD, Principal Advisor, Health Care Access Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub\\-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 1 August 1990.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nAmpicillin Trihydrate with Purified Water B.P.\n\nChloral Hydrate\n\nChlorpromazine\n\nClopamide\n\nDiloxanide Furoate\n\nFenoterol Hydrobromide\n\nLindane\n\n“Locasol New Formula”\n\nPrimaquine Phosphate\n\nSulphafurazole\n\nTestosterone Propionate\n\nTetracycline Hydrochloride with a buffering agent and Nystatin\n\nTetracycline Hydrochloride with Nystatin\n\nThiopropazate Hydrochloride\n\nDated this twenty-fifth day of July 1990.\n\nMARGARET FORD\n\nPRINCIPAL ADVISOR\n\nHEALTH CARE ACCESS DIVISION\n\nDEPARTMENT OF COMMUNITY SERVICES AND HEALTH\n\nDELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1617},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The declaration performs exactly as originally intended: removing only the 13 specific listed drugs from the Pharmaceutical Benefits Scheme without expansion into other regulatory areas."},"complexity_factors":["Single operative provision with no conditional logic or exceptions","No interpretation section or defined terms","Simple tabular list format in the Schedule","Only one cross-reference to the empowering provision (s 85(2AA))"],"plain_english_summary":"This declaration removes 13 named medicines from Australia’s Pharmaceutical Benefits Scheme as of 1 August 1990, so they cease to be subsidised and patients must pay the full private price. Affected products include several antibiotics, some sedatives/antipsychotics, testosterone propionate, fenoterol hydrobromide and primaquine phosphate. It matters because delisting raises patient costs and typically signals low cost‑effectiveness, replacement by better alternatives, or rare use; the action is taken under s.85(2AA) of the National Health Act 1953."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-1990","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-1990/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-1990/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-1990/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-1990/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-5-of-1990/documents"}}